Conceptual models of drug-drug interactions: A summary of recent efforts
暂无分享,去创建一个
[1] Olivier Bodenreider,et al. Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies , 2015, J. Biomed. Informatics.
[2] Amedeo Napoli,et al. Suggested Ontology for Pharmacogenomics (SO-Pharm): Modular Construction and Preliminary Testing , 2006, OTM Workshops.
[3] Peter L. Elkin,et al. Initializing the VA medication reference terminology using UMLS metathesaurus co-occurrences , 2002, AMIA.
[4] Paloma Martínez,et al. Turning user generated health-related content into actionable knowledge through text analytics services , 2016, Comput. Ind..
[5] Jodi Schneider,et al. Towards a foundational representation of potential drug-drug interaction knowledge. , 2014, CEUR workshop proceedings.
[6] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.
[7] C E Lipscomb,et al. Medical Subject Headings (MeSH). , 2000, Bulletin of the Medical Library Association.
[8] Paola Russo,et al. A system for the extraction and representation of summary of product characteristics content , 2013, Artif. Intell. Medicine.
[9] M. Ashburner,et al. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration , 2007, Nature Biotechnology.
[10] David S. Wishart,et al. DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..
[11] Christopher G. Chute,et al. BioPortal: ontologies and integrated data resources at the click of a mouse , 2009, Nucleic Acids Res..
[12] Christoph Steinbeck,et al. Recent Developments in the ChEBI Ontology , 2011, ICBO.
[13] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[14] Kent A. Spackman,et al. SNOMED clinical terms: overview of the development process and project status , 2001, AMIA.
[15] Akihiko Konagaya,et al. Towards an In Silico Approach to Personalized Pharmacokinetics , 2012 .
[16] Mathias Brochhausen,et al. Formalizing Knowledge and Evidence about Potential Drug-drug Interactions , 2015, BDM2I@ISWC.
[17] Pieter de Vries Robbé,et al. A formal framework of knowledge to support rational psychoactive drug selection , 2001, Artif. Intell. Medicine.
[18] Paolo Terenziani,et al. An ontological knowledge and multiple abstraction level decision support system in healthcare , 2014, Decis. Anal..
[19] Ira J. Kalet,et al. Modeling Drug Mechanism Knowledge Using Evidence and Truth Maintenance , 2007, IEEE Transactions on Information Technology in Biomedicine.
[20] Mathias Brochhausen,et al. Towards a Consistent and Scientifically Accurate Drug Ontology , 2013, ICBO.
[21] Ira J. Kalet,et al. Computing with evidence: Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment , 2009, J. Biomed. Informatics.
[22] María Herrero Zazo. Semantic resources in pharmacovigilance: a corpus and an ontology for drug-drug interactions , 2015 .
[23] Atif Khan,et al. Integrating Machine Learning Into a Medical Decision Support System to Address the Problem of Missing Patient Data , 2012, 2012 11th International Conference on Machine Learning and Applications.
[24] Kazuhiko Ohe,et al. Development of Description Framework of Pharmacodynamics Ontology and Its Application to Possible Drug-drug Interaction Reasoning , 2013, MedInfo.
[25] Jingcheng Du,et al. Extracting drug-enzyme relation from literature as evidence for drug drug interaction , 2016, J. Biomed. Semant..
[26] Ira J. Kalet,et al. Computing with evidence: Part II: An evidential approach to predicting metabolic drug-drug interactions , 2009, J. Biomed. Informatics.
[27] Xiaowei Xu,et al. Mining FDA drug labels using an unsupervised learning technique - topic modeling , 2011, BMC Bioinformatics.
[28] John R Horn,et al. Proposal for a New Tool to Evaluate Drug Interaction Cases , 2007, The Annals of pharmacotherapy.
[29] María Herrero-Zazo,et al. Application of Machine Learning in Knowledge Discovery for Pharmaceutical Drug-drug Interactions , 2016, KDWeb.
[30] Antoni Olivé,et al. Conceptual modeling of information systems , 2007 .
[31] Michael A. Wittie,et al. Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support , 2015, Drug Safety.
[32] Carole A. Goble,et al. A descriptive semantic formalism for medicine , 1993, Proceedings of IEEE 9th International Conference on Data Engineering.
[33] Nicole Tourigny,et al. Bio2RDF: Towards a mashup to build bioinformatics knowledge systems , 2008, J. Biomed. Informatics.
[34] Hans-Michael Müller,et al. Textpresso: An Ontology-Based Information Retrieval and Extraction System for Biological Literature , 2004, PLoS biology.
[35] Ming Yang,et al. Filtering big data from social media - Building an early warning system for adverse drug reactions , 2015, J. Biomed. Informatics.
[36] E. Molden,et al. Severity and Management of Drug–Drug Interactions in Acute Geriatric Patients , 2013, Drugs & Aging.
[37] Paloma Martínez,et al. SemEval-2013 Task 9 : Extraction of Drug-Drug Interactions from Biomedical Texts (DDIExtraction 2013) , 2013, *SEMEVAL.
[38] Olivier Bodenreider,et al. Evaluating drug-drug interaction information in NDF-RT and DrugBank , 2015, J. Biomed. Semant..
[39] Cui Tao,et al. OAE: The Ontology of Adverse Events , 2014, J. Biomed. Semant..
[40] Luis Tari,et al. Semantic Inference for Pharmacokinetic Drug-Drug Interactions , 2014, 2014 IEEE International Conference on Semantic Computing.
[41] Paloma Martínez,et al. DINTO: Using OWL Ontologies and SWRL Rules to Infer Drug-Drug Interactions and Their Mechanisms , 2015, J. Chem. Inf. Model..
[42] Judith A. Blake,et al. Gene Ontology annotations: what they mean and where they come from , 2008, BMC Bioinformatics.
[43] Xu Han,et al. An integrated pharmacokinetics ontology and corpus for text mining , 2013, BMC Bioinformatics.
[44] Paloma Martínez,et al. Pharmacovigilance through the development of text mining and natural language processing techniques , 2015, J. Biomed. Informatics.
[45] O Bodenreider,et al. Biomedical ontologies in action: role in knowledge management, data integration and decision support. , 2008, Yearbook of medical informatics.
[46] E. Olvey,et al. Comparison of Critical Drug–Drug Interaction Listings: The Department of Veterans Affairs Medical System and Standard Reference Compendia , 2010, Clinical pharmacology and therapeutics.
[47] Jeffrey Aronson. Communicating information about drug interactions , 2007 .
[48] Sumi Yoshikawa,et al. Drug Interaction Ontology (DIO) for Inferences of Possible Drug-drug Interactions , 2004, MedInfo.
[49] Patrice Degoulet,et al. Modeling and Acquisition of Drug-Drug Interaction Knowledge , 2007, MedInfo.
[50] Peter J. F. Lucas,et al. Foundations of Biomedical Knowledge Representation , 2015, Lecture Notes in Computer Science.
[51] N. Shah,et al. Pharmacovigilance Using Clinical Notes , 2013, Clinical pharmacology and therapeutics.
[52] Asunción Gómez-Pérez,et al. Selecting and Customizing a Mereology Ontology for its Reuse in a Pharmaceutical Product Ontology , 2008, FOIS.
[53] Paloma Martínez,et al. Lessons learnt from the DDIExtraction-2013 Shared Task , 2014, J. Biomed. Informatics.
[54] Silvana Quaglini,et al. Summary of Product Characteristics content extraction for a safe drugs usage , 2012, J. Biomed. Informatics.
[55] Paloma Martínez,et al. Application of Domain Ontologies to Natural Language Processing: A Case Study for Drug-Drug Interactions , 2015, Int. J. Inf. Retr. Res..
[56] Maria Liakata,et al. Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness , 2013, J. Biomed. Semant..
[57] Ira J. Kalet,et al. Qualitative Pharmacokinetic Modeling of Drugs , 2005, AMIA.
[58] W. Paul Nichol,et al. Research Paper: Practitioners' Views on Computerized Drug-Drug Interaction Alerts in the VA System , 2007, J. Am. Medical Informatics Assoc..
[59] Stefano Spaccapietra,et al. Modular Ontologies: Concepts, Theories and Techniques for Knowledge Modularization , 2009, Modular Ontologies.